Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: A systematic review and meta-analysis

Parasites and Vectors

Volumn 4, Issue 1, 2011, Pages

  Liu, Rong ^a   Dong, Hui Fen ^a   Guo, Yi ^a   Zhao, Qin Ping ^a   Jiang, Ming Sen ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

artemether; artesunate; efficacy; human schistosomiasis; meta analysis; praziquantel

Indexed keywords

ARTEMETHER; ARTESUNATE; PLACEBO; PRAZIQUANTEL; ANTISCHISTOSOMAL AGENT; ARTEMISININ DERIVATIVE; DRUG DERIVATIVE;

ABDOMINAL PAIN; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DATA BASE; DIARRHEA; DIZZINESS; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEVER; HEADACHE; HUMAN; MEDLINE; META ANALYSIS; MONOTHERAPY; MORBIDITY; NAUSEA; OLIGOPHRENIA; PEER REVIEW; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHISTOSOMIASIS; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS JAPONICA; SCHISTOSOMIASIS MANSONI; SINGLE DRUG DOSE; STOMACH DISCOMFORT; STOMACH PAIN; SYSTEMATIC REVIEW; TREATMENT DURATION; ANIMAL; DOSE RESPONSE; DRUG EFFECT; PARASITOLOGY; SCHISTOSOMA;

ARTESUNATE; SCHISTOSOMA;

ANIMALS; ARTEMISININS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PRAZIQUANTEL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHISTOSOMA; SCHISTOSOMIASIS; SCHISTOSOMICIDES;

EID: 80054087269     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-4-201     Document Type: Review

References (118)

1. The global status of schistosomiasis and its control. Chitsulo L, Engels D, Montresor A, Savioli L, Acta Trop 2000 77 41 51 10.1016/S0001-706X(00)00122-4 10996119
2. Reassessment of the cost of chronic helminthic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. King CH, Dickman K, Tisch DJ, Lancet 2005 365 1561 1569 10.1016/S0140-6736(05)66457-4 15866310 (Pubitemid 40615405)
3. Human schistosomiasis. Gryseels B, Polman K, Clerinx J, Kestens L, Lancet 2006 368 1106 1118 10.1016/S0140-6736(06)69440-3 16997665 (Pubitemid 44402679)
4. Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Utzinger J, Raso G, Brooker S, De Savigny D, Tanner M, Ornbjerg N, Singer BH, N'goran EK, Parasitology 2009 136 1859 1874 10.1017/S0031182009991600 19906318
5. Measuring the burden of neglected tropical diseases: the global burden of disease framework. Mathers CD, Ezzati M, Lopez AD, PLoS Negl Trop Dis 2007 1 114 10.1371/journal.pntd.0000114 18060077 (Pubitemid 352024647)
6. Control of neglected tropical diseases. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, Savioli L, N Engl J Med 2007 357 1018 1027 10.1056/NEJMra064142 17804846 (Pubitemid 47367081)
7. Helminth infections: the great neglected tropical diseases. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J, J Clin Invest 2008 118 1311 1321 10.1172/JCI34261 18382743 (Pubitemid 351500423)
8. Schistosomiasis. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, McManus DP, N Engl J Med 2002 346 1212 1220 10.1056/NEJMra012396 11961151 (Pubitemid 34984584)
9. Current status of vaccines for schistosomiasis. McManus DP, Loukas A, Clin Microbiol Rev 2008 21 225 242 10.1128/CMR.00046-07 18202444 (Pubitemid 351160017)
10. The role of chemotherapy in schistosomiasis control. WHO/SCHISTO, Geneva WHO 1983 70
11. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Doenhoff MJ, Cioli D, Utzinger J, Curr Opin Infect Dis 2008 21 659 667 10.1097/QCO.0b013e328318978f 18978535
12. Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. Botros S, Sayed H, Amer N, El-Ghannam M, Bennett JL, Day TA, Int J Parasitol 2005 35 787 791 10.1016/j.ijpara.2005.02.005 15925597 (Pubitemid 40733617)
13. Evidence against rapid emergence of praziquantel resistance in S. haematobium, Kenya. King CH, Muchiri EM, Ouma JH, Emerg Infect Dis 2000 6 585 594 10.3201/eid0606.000606 11076716 (Pubitemid 32110500)
14. Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa. Silva IM, Thiengo R, Conceição MJ, Rey L, Lenzi HL, Pereira Filho E, Ribeiro PC, Mem Inst Oswaldo Cruz 2005 100 445 449 16113896 (Pubitemid 41190700)
15. Failure of standard treatment with praziquantel in two returned travellers with Schistosoma haematobium infection. Alonso D, Mũoz J, Gascán J, Valls ME, Corachan M, Am J Trop Med Hyg 2006 74 342 344 16474094 (Pubitemid 46774351)
16. Research progress of schistosomiasis japonica chemotherapy. Wang ZH, Hubei J Prev Med 2000 11 1 3 (in Chinese)
17. In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Xiao SH, Catto BA, Antimicrob Agents Chemother 1989 33 1557 1562 2510595 (Pubitemid 19228014)
18. Experimental studies on early treatment of schistosomal infection with artemether. Xiao SH, You JQ, Yang YQ, Wang CZ, Southeast Asian J Trop Med Public Health 1995 26 306 318 8629066
19. Effect of artemether against Schistosoma haematobium in experimentally infected hamsters. Xiao SH, Utzinger J, Chollet J, Endriss Y, N'Goran EK, Tanner M, Int J Parasitol 2000 30 1001 1006 10.1016/S0020-7519(00)00091-6 10980290 (Pubitemid 30649677)
20. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Utzinger J, Keiser J, Xiao SH, Tanner M, Singer BH, Antimicrob Agents Chemother 2003 47 1487 1495 10.1128/AAC.47.5.1487-1495.2003 12709312 (Pubitemid 36548527)
21. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Xiao SH, Tanner M, N'Goran EK, Utzinger J, Chollet J, Bergquist R, Chen MG, Zheng J, Acta Trop 2002 82 175 181 10.1016/S0001-706X(02)00009-8 12020890 (Pubitemid 34518567)
22. Cochrane Handbook for Systematic Reviews of Interventions Version 4.2.6 [updated September 2006]. Higgins JPT, Green S, (editors), The Cochrane Collaboration 2006 http://www.cochrane.org/resources/handbook/
23. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ, Control Clin Trials 1996 17 1 12 10.1016/0197-2456(95) 00134-4 8721797 (Pubitemid 26120810)
24. Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria. Inyang-Etoh PC, Ejezie GC, Useh MF, Inyang-Etoh EC, Trans R Soc Trop Med Hyg 2009 103 38 44 10.1016/j.trstmh.2008. 08.002 18838149
25. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Touré S, Zhang Y, Bosqué-Oliva E, Ky C, Ouedraogo A, Koukounari A, Gabrielli AF, Bertrand S, Webster JP, Fenwick A, Bull World Health Organ 2008 86 780 787 10.2471/BLT.07.048694 18949215
26. Controlling schistosomiasis: significant decrease of anaemia prevalence one year after a single dose of praziquantel in Nigerien schoolchildren. Tohon ZB, Mainassara HB, Garba A, Mahamane AE, Bosqué-Oliva E, Ibrahim ML, Duchemin JB, Chanteau S, Boisier P, PLoS Negl Trop Dis 2008 2 241 248 10.1371/journal.pntd.0000241 18509472 (Pubitemid 352002902)
27. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa. Saathoff E, Olsen A, Magnussen P, Kvalsvig JD, Becker W, Appleton CC, BMC Infect Dis 2004 4 40 49 10.1186/1471-2334-4-40 15471549 (Pubitemid 39615388)
28. Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among school children from Côte d'Ivoire. N'Goran EK, Gnaka HN, Tanner M, Utzinger J, Ann Trop Med Parasitol 2003 97 37 51 10.1179/000349803125002553 12662421 (Pubitemid 36279014)
29. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. Borrmann S, Szlezák N, Faucher JF, Matsiegui PB, Neubauer R, Binder RK, Lell B, Kremsner PG, J Infect Dis 2001 184 1363 1366 10.1086/324004 11679932 (Pubitemid 33055588)
30. Continued ultrasonic follow-up of children infected with Schistosoma haematobium after treatment with praziquantel. Campagne G, Garba A, Barkiré H, Vera C, Sidiki A, Chippaux JP, Trop Med Int Health 2001 6 24 30 10.1046/j.1365-3156.2001.00660.x 11263461 (Pubitemid 32221294)
31. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Tanner M, Trop Med Int Health 2000 5 771 778 10.1046/j.1365-3156. 2000.00646.x 11123824 (Pubitemid 32001036)
32. Treatment of Schistosoma mekongi with praziquantel: a double-blind study. Nash TE, Hofstetter M, Cheever AW, Ottesen EA, Am J Trop Med Hyg 1982 31 977 982 6751116 (Pubitemid 12030531)
33. Preliminary clinical trials with praziquantel in Schistosoma japonicum infections in the Philippines. Santos AT, Blas BL, Nosẽas JS, Portillo GP, Ortega OM, Hayashi M, Boehme K, Bull World Health Organ 1979 57 793 799 396056 (Pubitemid 10177802)
34. Praziquantel: a new schistosomicide against Schistosoma haematobium. McMahon JE, Kolstrup N, Br Med J 1979 2 1396 1399 10.1136/bmj.2.6202.1396 519476 (Pubitemid 10210245)
35. Preliminary trials with praziquantel in human infections due to Schistosoma mansoni. Katz N, Rocha RS, Chaves A, Bull World Health Organ 1979 57 781 785 396054 (Pubitemid 10177800)
36. Mass praziquantel chemoprophylaxis against acute schistosomiasis japonica in a flood. Huang YX, Rong GR, Xu GY, Wang XD, Yang HM, Song HT, Zhang XB, Tu YX, Chin J Schisto Control 1998 10 138 140 (in Chinese)
37. Effect of intermittent medication with praziquantel for treating schistosomiasis japonica in the endemic seasons. Liu ZG, Chin J Parasit Dis Control 1997 10 21 (in Chinese)
38. Effect of oral artemether in controlling schistosomiasis in a heavy endemic area of Nanji town, Xinjian county, Jiangxi province. Song Y, Bao ZP, Gao ZL, Ning A, Hu QL, Chen MG, Chen FJ, Ge J, Xiao SH, Zhou XN, Xu J, J Trop Med 2006 6 1182 1185 (in Chinese)
39. A double-blind field trial on the effects of artemether on Schistosoma japonicum infection in a highly endemic focus in southern China. Li YS, Chen HG, He HB, Hou XY, Ellis M, McManus DP, Acta Trop 2005 96 184 190 10.1016/j.actatropica.2005.07.013 16112071 (Pubitemid 41463749)
40. Randomized, double-blind, placebo-control trial of oral artemether for the prevention of patent Schistosoma haematobium infections. N'Goran EK, Utzinger J, Gnaka HN, Yapi A, N'Guessan NA, Kigbafori SD, Lengeler C, Chollet J, Xiao SH, Tanner M, Am J Trop Med Hyg 2003 68 24 32 12556143 (Pubitemid 38234842)
41. Oral artemether for prevention of Schistosoma mansoni infection: randomized controlled trial. Utzinger J, N'Goran EK, N'Dri A, Tanner M, Lancet 2000 355 1320 1325 10.1016/S0140-6736(00)02114-0 10776745 (Pubitemid 30199004)
42. Reduction of Schistosoma japonicum infection in an endemic area in Islet with embankment after prophylaxis with oral artemether throughout the transmission season. Tian ZY, Xiao SH, Xiao JW, Liu DS, Zhou YC, Zheng J, Chen MG, Qu GS, Zhang XY, Yao XM, Zhang XZ, Zhang DL, Huang GX, Chin J Parasito Parasitic Dis 1997 15 208 211 (in Chinese)
43. Efficacy investigation of fishermen taking oral artemether on schistosomiasis prevention in Muping Lake. Tian ZY, Liu DS, Xiao JW, Yao XM, Zhou YC, Qu GS, Zhang XR, Chin J Schisto Control 1999 11 317 (in Chinese)
44. Preliminary investigation of effect of artemether in people working with water on schistosomiasis prevention. Huang AS, Zhou B, Chen WY, Sheng QH, Jing GY, Xiao CY, Xiao SH, Chen MG, Zheng J, Liu HX, Chin J Schisto Control 1999 11 161 (in Chinese)
45. Preventive effect of artemether on schistosome infection. Song Y, Xiao S, Wu W, Zhang S, Xie H, Xu X, Hu X, Cui Q, Chen M, Zheng J, Chin Med J (Engl) 1998 111 123 127 (Pubitemid 28163416)
46. Observation on the effect of artemether on controlling schistosomiasis japonica in an endemic area of marshland. Xu MS, Xiao SH, Song Q, Tao CG, Xia CG, Wang H, Chen MG, Zheng J, Piao CH, Hu FY, Ou N, Zhang XS, Chin J Parasito Parasitic Dis 1997 15 212 215 (in Chinese)
47. Effect of oral artemether in controlling schistosomiasis in Yunnan mountainous endemic Area. Wang JL, Xiao SH, Yang Z, Huang MH, Yang H, Liu YH, Zhou GS, Zheng J, Chen MG, Chin J Parasitol Parasitic Dis 1997 15 138 142 (in Chinese)
48. Field studies on preventive effect of artemether against infection with Schistosoma japonicum. Xiao SH, Shi ZG, Zhuo SJ, Wang CZ, Zhang ZG, Chu B, Zheng J, Chen MG, Chin J Parasitol Parasitic Dis 1995 13 170 173 (in Chinese)
49. Protection of the residents from schistosome infection by oral artemether in mountainous endemic area. Xiao SH, Wang JL, Wang CZ, Yang Z, Chu B, Yang H, Liu YH, Zheng J, Chen MG, Chin J Parasitol Parasitic Dis 1996 14 11 14 (in Chinese)
50. Field study on preventive effect of artesunate against infection due to Schistosoma japonicum in an endemic area of marshlands. Xu MS, Zhu CG, Wang H, Gao FH, Wu YX, Cui DY, Zhang XZ, Ou N, Wu ZX, J Trop Dis Parasitol 1996 25 198 201 (in Chinese)
51. Field appliance of oral artesunate for prevention of schistosomiasis japonica. Xu MS, Zhang SQ, Wang TP, Fang GR, Wang QZ, He JC, Zhang GH, Chen JR, Li JT, Lu YS, Li XS, Xu CS, Bao JR, Yu MX, Huang FY, Ou N, Zhang XS, Piao CH, Hu FY, Cui DY, J Trop Dis Parasitol 1998 7 68 71 (in Chinese)
52. The effect analysis of using artesunate to prevent schistosome infection in the field. Xu MS, Chin J Parasit Dis Control 2001 14 26 27 (in Chinese)
53. Study of artesunate in preventing schistosome infection in river beach area. Cui JF, Lu GY, Lin GJ, Sun MX, Jiang J, Wu QZ, Li JS, Anhui Prev Med 2001 7 129 130 (in Chinese)
54. Field investigation of oral artesunate for preventing high risk population from schistosome infection. Sun MX, Jiang J, Lu GY, Lin GJ, Cui JF, Wu QZ, Li JS, Anhui J Prev Med 2000 6 442 (in Chinese)
55. Clinical trials on preventive effect of artesunate on schistosomiasis japonica. Zhang SJ, Lin DD, Liu YM, Liu HY, Liu ZD, Hu LS, Gao ZL, Hu F, Xu MS, Yi ZH, Wu LJ, Li SW, Mod Diagn Treat 2000 11 68 72 (in Chinese)
56. Clinical observation of oral artesunate for preventing short-term exposure to infested water population from schistosomiasis. Yi ZH, Lu M, Feng DC, Wang ZH, Xiang CP, Gou ZQ, Li SW, Wu LJ, Chin J Schisto Control 2000 12 100 101 (in Chinese)
57. Observation on the prevention of schistosomiasis japonica by administration of artesunate long term. Liu HY, Liu ZD, Hu LS, Liu YM, Zhang SJ, Hu F, Cheng XY, Li SW, Wu LJ, Xu FS, Xuan YX, Guo Y, Chin J Parasitic Dis Control 1999 12 214 215 (in Chinese)
58. Expanded experimental study on the prevention of schistosomiasis japonica by oral artesunate. Liu ZD, Hu LS, Liu YM, Hu GH, Hu F, Qiu YX, Gao ZL, Liu HY, Li JY, Su LH, Chin J Parasitic Dis Control 1996 9 37 39 (in Chinese)
59. Field application of artesunate in prophylaxis of schistosomiasis: an observation of 346 cases. Wu LJ, Li SW, Xuan YX, Xu PS, Liu ZD, Hu LS, Zhou SY, Qiu YX, Liu YM, Chin J Schisto Control 1995 7 323 327 (in Chinese)
60. A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China. Hou XY, McManus DP, Gray DJ, Balen J, Luo XS, He YK, Ellis M, Williams GM, Li YS, Bull World Health Organ 2008 86 788 795 10.2471/BLT.08.053041 18949216
61. Observation of the efficacy on schistosomiasis prevention with artesunate and praziquantel. Xia CS, Zhao XY, Liu YF, Jiang ZH, Li NP, J Prev Med Chin PLA 2000 18 120 121 (in Chinese)
62. Efficacy investigation of praziquantel in schistosomiasis prevention. Liu ZG, Yuan XB, Hubei J Prev Med 1997 8 30 31 (in Chinese)
63. The preventive effect of artemether in protection of people from schistosome infection during fighting against flood. Song Y, Xiao SH, Wu W, Zhang SJ, Xie HQ, Xu XP, Hu XY, Cui Q, Chen MG, Zheng J, Chin J Parasitol Parasitic Dis 1997 15 133 137 (in Chinese)
64. Studies on effect of artemether to control infection and prevent acute infection of Schistosoma japonicum in high endemic areas. Chen HG, Lin DD, Li YS, Liu YM, McManus DP, Huang XH, Feng Z, Chin J Schisto Control 2006 18 32 35 (in Chinese)
65. Study on preventive effect of artesunate against infection due to Schistosoma japonicum in an endemic area of marshlands. Xu MS, Zhu CG, Wang H, Gao FH, Wu YX, Cui DY, Zhang XZ, Ou N, Wu ZX, Chin J Schisto Control 1997 9 268 271 (in Chinese)
66. Clinical research of combination praziquantel and artemether in treating acute schistosomiasis japonica. Hou XY, Li YS, Luo XS, He YK, Yu XL, Fu X, Zhou J, Shi MZ, Liu ZC, Wang YY, Li Y, Wei WY, Chin J Schisto Control 2006 18 99 102 (in Chinese)
67. Double blind investigation of praziquantel in treating schistosomiasis japonica. Huang YX, Wang WF, Xue ZQ, Yang SJ, Chen YQ, Wu YX, Zhou JX, Jiangsu Med Drug 1983 1 19 21 (in Chinese)
68. A multi-centre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil. Olliaro PL, Vaillant MT, Belizario VJ, Lwambo NJ, Ouldabdallahi M, Pieri OS, Amarillo ML, Kaatano GM, Diaw M, Domingues AC, Favre TC, Lapujade O, Alves F, Chitsulo L, PLoS Negl Trop Dis 2011 5 1165 10.1371/journal.pntd.0001165 21695161
69. The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China. Hua HY, Liang YS, Zhang Y, Wei JF, Guo HX, Parasitol Res 2010 107 873 878 10.1007/s00436-010-1944-5 20549236
70. Clinical analysis of praziquantel in treating schistosomiasis japonica: 1107 cases report. Zhou ZB, Li WT, Xiong SL, Xu YB, Li YB, Lan YH, Zhao CG, Rao CD, Mao AJ, Liu SQ, Du GY, Li Y, Yunnan Med Drug 1983 4 148 152 (in Chinese)
71. Conquering schistosomiasis in China: the long march. Utzinger J, Zhou XN, Chen MG, Bergquist R, Acta Trop 2005 96 69 96 16312039 (Pubitemid 41472039)
72. Chemical treatment of schistosomiasis japonica in China. Wang ZH, J Clin Intern Med 2006 23 302 304 (in Chinese)
73. Study on prevention and cure of artemether against schistosomiasis. Xiao SH, Chin J Schisto Control 2005 17 310 320 (in Chinese)
74. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Xiao SH, Acta Trop 2005 96 153 167 10.1016/j.actatropica.2005.07.010 16112072 (Pubitemid 41463746)
75. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Midzi N, Sangweme D, Zinyowera S, Mapingure MP, Brouwer KC, Kumar N, Mutapi F, Woelk G, Mduluza T, Trans R Soc Trop Med Hyg 2008 102 759 766 10.1016/j.trstmh.2008.03. 010 18486169
76. Chemotherapeutic drugs against schistosomiasis japonica. Ma YJ, Guo M, Liu JF, Endemic Dis Bull 2007 22 68 69 (in Chinese)
77. Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel. Xiao SH, Yue WJ, Yang YQ, You JQ, Chin Med J (Engl) 1987 100 759 768
78. Mefloquine - an aminoalcohol with promising antischistosomal properties in mice. Keiser J, Chollet J, Xiao SH, Mei JY, Jiao PY, Utzinger J, Tanner M, PLoS Negl Trop Dis 2009 3 350 10.1371/journal.pntd.0000350 19125172
79. A 19-year follow-up study on praziquantel treatment for schistosomiasis. Wu WL, Huang YY, Zhou XZ, Wang JX, Zhang SY, Zhang YM, Lu JY, He WB, Lang YG, Tang HJ, Yang SG, Chin J Schisto Control 1998 10 215 217 (in Chinese)
80. Praziquantel for the treatment of schistosomiasis mansoni during pregnancy. Adam I, Elwasila E, Homeida M, Ann Trop Med Parasitol 2005 99 37 40 10.1179/136485905X17407 15701253
81. Schistosome resistance to praziquantel: Fact or artifact? Fallon PG, Tao LF, Ismail MM, Bennett JL, Parasitol Today 1996 12 316 320 10.1016/0169-4758(96) 10029-6 15275183 (Pubitemid 26228577)
82. Schistosome resistance to praziquantel. Fallon PG, Drug Resist Updat 1998 1 236 241 10.1016/S1368-7646(98)80004-6 16904406
83. Human schistosomiasis resistance to praziquantel in china: should we be worried? Seto EY, Wong BK, Lu D, Zhong B, Am J Trop Med Hyg 2011 85 74 82 10.4269/ajtmh.2011.10-0542 21734129
84. Experimental study on susceptibility of praziquantel against Schistosoma japonicum in repeated chemotherapy areas in Dongting Lake region. Shi MZ, Yu DB, Wei WY, Zhang CS, He HB, Yang GF, Li GP, Ren MY, Chin J Schisto Contr 2004 16 171 173 (in Chinese)
85. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Doenhoff MJ, Pica-Mattoccia L, Expert Rev Anti Infect Ther 2006 4 199 210 10.1586/14787210.4.2.199 16597202
86. Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Danso-Appiah A, de Vlas SJ, Trends Parasitol 2002 18 125 129 10.1016/S1471-4922(01)02209-7 11854090 (Pubitemid 34164257)
87. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Ismail M, Metwally A, Farghaly A, Bruce J, Tao LF, Bennett JL, Am J Trop Med Hyg 1996 2 214 218 (Pubitemid 26299209)
88. In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel. Liang YS, Coles GC, Doenhoff MJ, Southgate VR, Int J Parasitol 2001 11 1227 1235 (Pubitemid 32762993)
89. Field evaluation of a test for praziquantel resistance in Schistosoma sp. Kenworthy JD, Ye P, Wu GC, Yu H, Shi YJ, Li H, Coles GC, Vet Parasitol 2003 1 83 87 (Pubitemid 36332252)
90. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Ismail M, Botros S, Metwally A, William S, Farghally A, Tao LF, Day TA, Bennett JL, Am J Trop Med Hyg 1999 60 932 395 10403323
91. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Gryseels B, Mbaye A, de Vlas SJ, Stelma FF, Guissé F, Van Lieshout L, Faye D, Diop M, Ly A, Tchuem-Tchuenté LA, Engels D, Polman K, Trop Med Int Health 2001 6 864 873 10.1046/j.1365-3156.2001.00811.x 11703840 (Pubitemid 33010872)
92. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. King CH, Muchiri EM, Ouma JH, Emerg Infect Dis 2000 6 585 594 10.3201/eid0606.000606 11076716 (Pubitemid 32110500)
93. Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel. Kasinathan RS, Morgan WM, Greenberg RM, Mol Biochem Parasitol 2010 173 25 31 10.1016/j.molbiopara.2010.05.003 20470831
94. Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Doenhoff MJ, Hagan P, Cioli D, Southgate V, Pica-Mattoccia L, Botros S, Coles G, Tchuem Tchuenté LA, Mbaye A, Engels D, Parasitology 2009 136 1825 1835 10.1017/S0031182009000493 19281637
95. Studies on the efficacy of artemether in experimental schistosomiasis. Le WJ, You JQ, Yang YQ, Mei JY, Guo HF, Yang HZ, Zhang CW, Acta Pharm Sin 1982 17 187 193
96. Chemotherapeutic effect of artesunate in experimental schistosomiasis. Le WJ, You JQ, Mei JY, Acta Pharm Sin 1983 18 619 621
97. Experimental studies on antischistosomal activity of qinghaosu. Chen DJ, Fu LF, Shao PP, Wu FZ, Shu H, Ren CS, Sheng XL, Zhong Hua Yi Xue Zha Zhi 1980 60 422 425
98. Artemether treatment of prepatent Schistosoma japonicum induces resistance to reinfection in association with reduced pathology. Bartley PB, Glanfield A, Li YS, Stanisic DI, Duke M, Jones MK, McManus DP, Am J Trop Med Hyg 2008 78 929 935 18541772 (Pubitemid 351967811)
99. The potential of artemether for the control of schistosomiasis. Utzinger J, Xiao SH, N'Goran EK, Bergquist R, Tanner M, Int J Parasitol 2001 31 1549 1562 10.1016/S0020-7519(01)00297-1 11730781 (Pubitemid 33152809)
100. Development of the drug to prevent schistosomiasis japonica. Zhou J, Wu GH, Chin J Dis Control Prev 2002 6 71 73 (in Chinese)
101. Study on prevention and cure of artemether against schistosomiasis. Xiao SH, Chin J Schisto Control 2005 17 310 320 (in Chinese)
102. Research on artemether and artesunate for prevention of schistosomiasis. Division of Science and Education of Chinese Ministry of Health, China Medical News 1999 13 6 8 (in Chinese)
103. Research progress of artemisinin, artemether and artesunate used for schistosomiasis prevention. Xu MS, Chin J Schisto Control 1998 4 251 253 (in Chinese)
104. The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China. Hua HY, Liang YS, Zhang Y, Wei JF, Guo HX, Parasitol Res 2010 107 873 878 10.1007/s00436-010-1944-5 20549236
105. The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China? Liu R, Dong HF, Jiang MS, Parasitol Res 2011 10.1007/s00436-011-2641-8
106. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
107. Has artemisinin resistance spread already? Editorial, Lancet 2011 377 272 21322839
108. WHO urges the phasing out of artemisinin based monotherapy for malaria to reduce resistance. Cui W, BMJ 2011 342 2793 10.1136/bmj.d2793 21543403
109. Diagnostic dilemmas in helminthology: what tools to use and when? Bergquist R, Johansen MV, Utzinger J, Trends Parasitol 2009 25 151 156 10.1016/j.pt.2009.01.004 19269899
110. Treatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review. Danso-Appiah A, Garner P, Olliaro PL, Utzinger J, Parasitology 2009 136 1837 1849 10.1017/ S0031182009005939 19493363
111. Efficacy investigation of praziquantel in treating different infection level schistosomiasis. Liu SJ, Cao HN, Tao B, Li QR, Cheng LG, Wu ZX, Xiong TS, Deng LX, Chen LH, Zuo XX, Song GX, Zhang R, Chin J Parasitol Parasitic Dis 1989 7 64 65 (in Chinese)
112. Evidence-based medicine. Li YP, (editor), Beijing: Higher Education Press 2003 (in Chinese)
113. Drugs for treating urinary schistosomiasis. Danso-Appiah A, Utzinger J, Liu J, Olliaro P, Cochrane Database Syst Rev 2008 3 D000053 18646057
114. Interventions for treating schistosomiasis mansoni. Saconato H, Atallah A, Cochrane Database Syst Rev 2000 2 D000528
115. Schistosomiasis control: experiences and lessons from China. Wang LD, Utzinger J, Zhou XN, Lancet 2008 372 1793 1795 10.1016/S0140-6736(08)61358-6 18930529
116. China's new strategy to block Schistosoma japonicum transmission: experiences and impact beyond schistosomiasis. Wang LD, Guo JG, Wu XH, Chen HG, Wang TP, Zhu SP, Zhang ZH, Steinmann P, Yang GJ, Wang SP, Wu ZD, Wang LY, Hao Y, Bergquist R, Utzinger J, Zhou XN, Trop Med Int Health 2009 14 1475 1483 10.1111/j.1365-3156.2009.02403.x 19793080
117. Social epidemiological thinking about schistosomiasis. Jiang MS, Liu R, Zhao QP, Dong HF, Guo Y, Chin J Schisto Contr 2010 22 201 205 (in Chinese)
118. Schistosomiasis elimination: lessons from the past guide the future. Gray DJ, McManus DP, Li YS, Williams GM, Bergquist R, Ross AG, Lancet Infect Dis 2010 10 733 736 10.1016/S1473-3099(10)70099-2 20705513